These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 26111832

  • 1. Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
    Compher C, Boullata JI, Pickett-Blakely O, Schiavone P, Stoner N, Kinosian BP.
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1183-1190. PubMed ID: 26111832
    [Abstract] [Full Text] [Related]

  • 2. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [Abstract] [Full Text] [Related]

  • 3. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K, Schwartz L, Batisti J, Iyer KR.
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [Abstract] [Full Text] [Related]

  • 4. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF.
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.
    O'Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B.
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):815-23.e1-3. PubMed ID: 23333663
    [Abstract] [Full Text] [Related]

  • 6. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [Abstract] [Full Text] [Related]

  • 7. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 8. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B, Herfarth HH.
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [Abstract] [Full Text] [Related]

  • 9. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
    Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E.
    Eur J Pediatr; 2024 Aug; 183(8):3173-3182. PubMed ID: 38664251
    [Abstract] [Full Text] [Related]

  • 10. Short bowel syndrome: highlights of patient management, quality of life, and survival.
    Kelly DG, Tappenden KA, Winkler MF.
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092
    [Abstract] [Full Text] [Related]

  • 11. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA, Edelman J, Joelsson B.
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [Abstract] [Full Text] [Related]

  • 13. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL, Fujioka K, Boullata JI, Iyer K, Lee HM, Ziegler TR.
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [Abstract] [Full Text] [Related]

  • 14. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T, Stoll B, Mecklenburg L, Burrin DG, Vegge A, Qvist N, Eriksen T, Jeppesen PB, Sangild PT.
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [Abstract] [Full Text] [Related]

  • 16. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A, To C, Alvarez A, Lara LF.
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [Abstract] [Full Text] [Related]

  • 18. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H.
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [Abstract] [Full Text] [Related]

  • 19. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R.
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [Abstract] [Full Text] [Related]

  • 20. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW, Hill S, Robinson I, Raphael BP, Matthews C, Cohran V, Carter B, Venick R, Kocoshis S.
    J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.